Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Multicenter, Randomized, Open-Label, Comparative Study of Therapeutic Efficacy, Safety and Tolerability of BNO 1030 application in the technology of delayed prescription of antibiotics in patients with severe acute tonsillitis

View ORCID ProfileV. I. Popovych, I. V. Koshel, O. N. Malofiichuk, L. I. Pyletska, O. A. Semeniuk, O. V. Martynnyk, R. N. Orlovska, O. I. Leta
doi: https://doi.org/10.1101/2021.03.10.21253255
V. I. Popovych
1Ivano-Frankivsk National Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for V. I. Popovych
  • For correspondence: popovychvasyl@gmail.com
I. V. Koshel
2Institute of Postgraduate Education, IFNMU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O. N. Malofiichuk
3Regional Clinical Hospital. OF Gerbachevsky ZhOR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. I. Pyletska
4Ivano-Frankivsk Regional Clinical Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O. A. Semeniuk
5Danylo Halytsky Lviv National Medical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O. V. Martynnyk
6KNP 1st city polyclinic of Lviv
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. N. Orlovska
7The first private child of the polyclinic. M. Ivano-Frankivsk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
O. I. Leta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Acute bacterial tonsillitis occurs in 20 –30 % of immunocompetent children; however, the frequency of antibacterial drug prescriptions reaches up to 90 %. Delayed antibiotic prescription is recommended by current guidelines. The study objective was to determine the efficacy of phytoneering extract BNO 1030 in the technology of delayed antibiotic prescription in patients with severe acute tonsillitis.

Methods In the multicenter, randomized, open-label, comparative study, 182 out of 200 randomized children with acute tonsillitis aged 6 –12 years completed the study. Evaluation criteria: a reduced severity of sore throat when swallowing and at rest, throat irritation at rest, hyperemia of the tonsils assessed by a physician according to a 4-point scale at each visit compared to Visit 1, dynamics of self-assessment of general well-being, intensity of sore throat and difficulty swallowing according to a 10-point visual analogue scale, frequency of antibiotic prescriptions, therapeutic benefit from BNO 1030 in days.

Results The use of phytotherapeutic medicinal product BNO 1030 in addition to the standard symptomatic treatment of severe acute tonsillitis provides a clinically significant, adequate reduction in the symptom severity assessed by a physician at V2 (p < 0.005). There are significant differences in the patient’s self-assessment of the symptoms from treatment Day 2 (p < 0.005). This allows to significantly reduce the duration of systemic antipyretic administration (p < 0.005). In the first days of treatment, when a decision on delay of antibiotic prescription is made, a therapeutic benefit in two days in patients of the treatment group was observed compared to the control group. The use of BNO 1030 in patients with severe acute tonsillitis significantly reduces, by 43.7 % or 2.3 times, the need for prescribing antibiotic therapy as part of the technology of delayed antibiotic prescription (p < 0.005). During treatment, no side effects and complications of the disease were recorded.

Conclusion BNO 1030 is a safe and effective medicinal product for the treatment of severe acute tonsillitis in children aged 6 –12 years. It provides a significant therapeutic benefit when administered in addition to standard symptomatic therapy and reduces the irrational antibiotic prescription.

Trial registration ClinicalTrials.gov Identifier: NCT04537819 https://clinicaltrials.gov/ct2/show/NCT04537819?term=ATi-2&draw=2&rank=1

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04537819

Clinical Protocols

https://clinicaltrials.gov/ct2/show/NCT04537819?term=ATi-2&draw=2&rank=1

Funding Statement

This Investigator Initiated Trial was funded by Bionorica

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The ethical committee of Ivano-Frankivsk National Medical University

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the data can be provided by the corresponding author.

https://clinicaltrials.gov/ct2/show/NCT04537819?term=ATi-2&draw=2&rank=1

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted March 12, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Multicenter, Randomized, Open-Label, Comparative Study of Therapeutic Efficacy, Safety and Tolerability of BNO 1030 application in the technology of delayed prescription of antibiotics in patients with severe acute tonsillitis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Multicenter, Randomized, Open-Label, Comparative Study of Therapeutic Efficacy, Safety and Tolerability of BNO 1030 application in the technology of delayed prescription of antibiotics in patients with severe acute tonsillitis
V. I. Popovych, I. V. Koshel, O. N. Malofiichuk, L. I. Pyletska, O. A. Semeniuk, O. V. Martynnyk, R. N. Orlovska, O. I. Leta
medRxiv 2021.03.10.21253255; doi: https://doi.org/10.1101/2021.03.10.21253255
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Multicenter, Randomized, Open-Label, Comparative Study of Therapeutic Efficacy, Safety and Tolerability of BNO 1030 application in the technology of delayed prescription of antibiotics in patients with severe acute tonsillitis
V. I. Popovych, I. V. Koshel, O. N. Malofiichuk, L. I. Pyletska, O. A. Semeniuk, O. V. Martynnyk, R. N. Orlovska, O. I. Leta
medRxiv 2021.03.10.21253255; doi: https://doi.org/10.1101/2021.03.10.21253255

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Otolaryngology
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (202)
  • Anesthesia (55)
  • Cardiovascular Medicine (497)
  • Dentistry and Oral Medicine (91)
  • Dermatology (57)
  • Emergency Medicine (170)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (220)
  • Epidemiology (5776)
  • Forensic Medicine (3)
  • Gastroenterology (223)
  • Genetic and Genomic Medicine (889)
  • Geriatric Medicine (89)
  • Health Economics (235)
  • Health Informatics (778)
  • Health Policy (401)
  • Health Systems and Quality Improvement (259)
  • Hematology (108)
  • HIV/AIDS (188)
  • Infectious Diseases (except HIV/AIDS) (6612)
  • Intensive Care and Critical Care Medicine (398)
  • Medical Education (120)
  • Medical Ethics (29)
  • Nephrology (94)
  • Neurology (864)
  • Nursing (46)
  • Nutrition (145)
  • Obstetrics and Gynecology (166)
  • Occupational and Environmental Health (268)
  • Oncology (521)
  • Ophthalmology (169)
  • Orthopedics (44)
  • Otolaryngology (108)
  • Pain Medicine (49)
  • Palliative Medicine (22)
  • Pathology (150)
  • Pediatrics (258)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (116)
  • Psychiatry and Clinical Psychology (998)
  • Public and Global Health (2273)
  • Radiology and Imaging (382)
  • Rehabilitation Medicine and Physical Therapy (176)
  • Respiratory Medicine (315)
  • Rheumatology (111)
  • Sexual and Reproductive Health (85)
  • Sports Medicine (83)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (35)
  • Urology (42)